Review: taking Citalopram hydrobromide and Clonazepam together


Summary

Drug interactions are reported among people who take Citalopram hydrobromide and Clonazepam together. This review analyzes the effectiveness and drug interactions between Citalopram hydrobromide and Clonazepam. It is created by eHealthMe based on reports of 4,097 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Citalopram hydrobromide and Clonazepam >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Citalopram Hydrobromide

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from Citalopram hydrobromide 23,711 users)

Clonazepam

Clonazepam has active ingredients of clonazepam. It is often used in stress and anxiety. (latest outcomes from Clonazepam 39,945 users)

On Jul, 21, 2016

4,097 people who take Citalopram Hydrobromide, Clonazepam are studied.


Number of reports submitted per year:

Citalopram hydrobromide and Clonazepam drug interactions.

Drug effectiveness over time:

Citalopram Hydrobromide:
  • < 1 month: 11.0% - (4 of 36 people)
  • 1 - 6 months: 22.0% - (16 of 70 people)
  • 6 - 12 months: 25.0% - (12 of 48 people)
  • 1 - 2 years: 27.0% - (13 of 48 people)
  • 2 - 5 years: 40.0% - (28 of 70 people)
  • 5 - 10 years: 35.0% - (13 of 37 people)
  • 10+ years: 32.0% - (9 of 28 people)
  • not specified: 50.0% - (1 of 2 people)
Clonazepam:
  • < 1 month: 56.0% - (21 of 37 people)
  • 1 - 6 months: 42.0% - (27 of 63 people)
  • 6 - 12 months: 56.0% - (25 of 44 people)
  • 1 - 2 years: 33.0% - (17 of 51 people)
  • 2 - 5 years: 66.0% - (60 of 90 people)
  • 5 - 10 years: 59.0% - (25 of 42 people)
  • 10+ years: 76.0% - (16 of 21 people)
  • not specified: 25.0% - (1 of 4 people)

Drug effectiveness by gender:

Citalopram Hydrobromide:
  • female: 27.0% - (63 of 231 people)
  • male: 30.0% - (33 of 108 people)
Clonazepam:
  • female: 56.0% - (135 of 241 people)
  • male: 51.0% - (57 of 111 people)

Drug effectiveness by age:

Citalopram Hydrobromide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 31.0% - (5 of 16 people)
  • 20-29: 24.0% - (13 of 53 people)
  • 30-39: 19.0% - (17 of 86 people)
  • 40-49: 31.0% - (25 of 79 people)
  • 50-59: 32.0% - (24 of 74 people)
  • 60+: 38.0% - (12 of 31 people)
Clonazepam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 29.0% - (5 of 17 people)
  • 20-29: 62.0% - (35 of 56 people)
  • 30-39: 52.0% - (49 of 94 people)
  • 40-49: 55.0% - (44 of 80 people)
  • 50-59: 58.0% - (43 of 73 people)
  • 60+: 50.0% - (16 of 32 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • hypotension
  • disorientation
  • loss of consciousness
  • mental status changes
  • pneumonia
  • post-thoracotomy pain syndrome
  • completed suicide
  • obsessive-compulsive personality disorder
  • fungal infection
1 - 6 months:
  • completed suicide
  • depression
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • suicidal ideation
  • fatigue
  • anxiety
  • blood urine
  • cor pulmonale chronic
  • cough
  • drug rash with eosinophilia and systemic symptoms
6 - 12 months:
  • cognitive deterioration
  • crying - excessive (0-6 months)
  • deep vein thrombosis
  • agoraphobia
  • anxiety disorder
  • depressed mood
  • diarrhoea aggravated
  • dizziness postural
  • intention tremor
  • muscle rigidity
1 - 2 years:
  • depression
  • dizziness
  • drug exposure during pregnancy
  • hypertension
  • asthenia
  • cerebrovascular accident
  • dysstasia
  • eye swelling
  • eyelid oedema
  • fatigue - chronic
2 - 5 years:
  • depression
  • pain
  • anxiety
  • type 2 diabetes mellitus
  • diarrhoea
  • suicide attempt
  • pancreatitis
  • abdominal pain
  • disorientation
  • dizziness
5 - 10 years:
  • depression
  • fatigue
  • anxiety
  • dizziness
  • nausea
  • suicide attempt
  • anger
  • dry mouth
  • headache
  • injury
10+ years:
  • left ventricular hypertrophy
  • muscle pain
  • coronary artery disease
  • depressed mood
  • depression post-operative
  • dizziness
  • dry mouth
  • exhaustion
  • movement disorder
  • multiple sclerosis
not specified:
  • anxiety
  • depression
  • pain
  • nausea
  • diabetes mellitus
  • dyspnoea
  • dizziness
  • headache
  • back pain
  • weight increased

Most common drug interactions by gender *:

female:
  • pain
  • depression
  • nausea
  • anxiety
  • dyspnoea
  • dizziness
  • diabetes mellitus
  • fatigue
  • fall
  • headache
male:
  • anxiety
  • depression
  • dizziness
  • nausea
  • diabetes mellitus
  • pain
  • dyspnoea
  • insomnia
  • suicidal ideation
  • headache

Most common drug interactions by age *:

0-1:
  • drug exposure during pregnancy
  • premature baby
  • akinesia
  • amniocentesis abnormal
  • apgar score low
  • blood ph decreased
  • camptodactyly congenital
  • cerebral haemorrhage
  • cholestasis
  • congenital multiplex arthrogryposis
2-9:
  • insomnia
  • irritability
  • urticaria
  • abnormal behaviour
  • aggression
  • bulimia nervosa
  • convulsion
  • eosinophilia myalgia syndrome
  • fatigue
  • rash pruritic
10-19:
  • anxiety
  • suicide attempt
  • suicidal ideation
  • depression
  • hallucination, auditory
  • insomnia
  • irritability
  • intentional self-injury
  • nausea
  • overdose
20-29:
  • abdominal pain
  • dizziness
  • completed suicide
  • oedema peripheral
  • chest pain
  • hypoglycaemia
  • type 2 diabetes mellitus
  • suicidal ideation
  • cholecystitis chronic
  • depression
30-39:
  • diabetes mellitus
  • depression
  • nausea
  • completed suicide
  • anxiety
  • weight increased
  • pain
  • headache
  • back pain
  • vomiting
40-49:
  • depression
  • pain
  • anxiety
  • diabetes mellitus
  • nausea
  • type 2 diabetes mellitus
  • suicidal ideation
  • arthralgia
  • weight increased
  • constipation
50-59:
  • pain
  • nausea
  • anxiety
  • dyspnoea
  • depression
  • dizziness
  • diarrhoea
  • back pain
  • headache
  • vomiting
60+:
  • dyspnoea
  • anxiety
  • pain
  • dizziness
  • nausea
  • asthenia
  • fall
  • fatigue
  • chest pain
  • back pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Citalopram hydrobromide and Clonazepam?

Can you answer these questions?

More questions for: Citalopram hydrobromide, Clonazepam

You may be interested in these reviews

More reviews for: Citalopram hydrobromide, Clonazepam

On eHealthMe, Citalopram hydrobromide (citalopram hydrobromide) is often used to treat depression. Clonazepam (clonazepam) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.